PERSPECTA

News from every angle

Back to headlines

Organogenesis Shares Rise on PuraPlyAM Success in Diabetic Foot Ulcers

Organogenesis saw its shares rise following the successful application of its PuraPlyAM product in treating diabetic foot ulcers.

7 Apr, 10:50 — 7 Apr, 10:50
PostShare

Sources

Showing 1 of 1 sources